Proteomic Signatures in Neuronal and Glial Cell Models of Niemann-Pick Disease Type C
Journal of the American Society for Mass Spectrometry · 2026
DOI: 10.1021/jasms.6c00184 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2026. Written by Olivia C Wagner and 7 co-authors. Institution: Department of Chemistry, University of Illinois Chicago, Chicago, Illinois60607, United States. Major MEDLINE topics: Niemann-Pick Disease, Type C, Neurons, Neuroglia, Proteome. 111 references. The full text is freely available in PubMed Central. Funded by: Dana?s Angel?s Research Trust, UIC Department of Chemistry, College of Liberal Arts and Sciences, Ara Parseghian Medical Research Foundation.
Abstract (original language)
Niemann-Pick disease type C (NPC) is a lysosomal storage disorder characterized by the accumulation of unesterified cholesterol and glycosphingolipids in the late endosomal/lysosomal system, resulting in region-specific neurodegeneration. While the mechanism through which defective NPC1 protein and thus altered cholesterol transport engenders neurodegeneration is unknown, selective reintroduction of the NPC1 gene in different cell types in the mouse brain can alleviate disease symptoms, suggesting that neuronal and glial cells may play distinct roles in disease mechanisms. Here, in an in vitro NPC model, we evaluate cell-specific changes in the proteome upon treatment with a small-molecule cholesterol-trafficking inhibitor, U18666A, which inhibits NPC1 function across three immortalized cell lines in the central nervous system (CNS): mouse hippocampal neuronal cells (HT-22), mouse microglial cells (SIM-A9), and human hybridized oligodendrocytes (MO3.13). Using nanoliquid chromatography–mass spectrometry (LC–MS) techniques, we observe 21 common proteins upregulated in all U18666A-treated cells. We also note that markers of activated microglia were significantly altered in SIM-A9 microglial cells, whereas cytoskeletal and membrane-related proteins were elevated in MO3.13. In HT-22 hippocampal neuronal cells, we identify protein changes associated with altered glucose metabolism and postulate that ATP-citrate lyase (ACLY), a protein central to multiple biological pathways, might play a role in responding to aberrant cholesterol trafficking and metabolism in NPC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, University of Illinois Chicago, Chicago, Illinois60607, United States.
ORCID profiles: Wenping Li, Stephanie M Cologna
Funding
- Dana?s Angel?s Research Trust
- UIC Department of Chemistry, College of Liberal Arts and Sciences
- Ara Parseghian Medical Research Foundation
- NIH HHS
- NINDS NIH HHS
- Support Of Accelerated Research for Niemann-Pick C
- National Institutes of Health
Cite
APA
Wagner, O. C., Nguyen, T. T. A., Javanshad, R., Pathmasiri, K. C., Boktor, S., Davy, E., Li, W., & Cologna, S. M. (2026). Proteomic Signatures in Neuronal and Glial Cell Models of Niemann-Pick Disease Type C. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.6c00184
Vancouver
Wagner OC, Nguyen TTA, Javanshad R, Pathmasiri KC, Boktor S, Davy E, et al. Proteomic Signatures in Neuronal and Glial Cell Models of Niemann-Pick Disease Type C. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.6c00184
BibTeX
@article{Wagner2026,
author = {Wagner, Olivia C and Nguyen, Thu T A and Javanshad, Roshan and Pathmasiri, Koralege C and Boktor, Stephanie and Davy, Erin and Li, Wenping and Cologna, Stephanie M},
title = {Proteomic Signatures in Neuronal and Glial Cell Models of Niemann-Pick Disease Type C},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2026},
doi = {10.1021/jasms.6c00184}
}
EUVIMED